Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 12/20 | 0.38 |
| ▸ | RXRB | P28702 | 8/20 | 0.38 |
| ▸ | RXRG | P48443 | 8/20 | 0.38 |
| ▸ | RARB | P10826 | 9/20 | 0.38 |
| ▸ | RARG | P13631 | 8/20 | 0.38 |
| ▸ | RARA | P10276 | 8/20 | 0.38 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.34 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.34 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.34 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.34 |
| ▸ | GPR3 | P46089 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26303729 | 1.00 | RXRA (0.38) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL26308242 | 1.00 | RXRA (0.38) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL26304537 | 0.97 | RARB (0.42) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL26304253 | 0.96 | RARB (0.42) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL26303726 | 0.93 | RXRA (0.38) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL26303495 | 0.93 | RXRA (0.38) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL26307474 | 0.86 | RARB (0.37) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL29331329 | 0.86 | RARB (0.37) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL29331127 | 0.86 | RARB (0.37) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL24794182 | 0.85 | RARB (0.38) | RXRARARBRARGRARAPTPN7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12048240-B2 | Organic compound, electronic component and electronic apparatus comprising the same | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2024-07-23 | — | — | US | disclosed |
| US-12048240-B2 | Organic compound, electronic component and electronic apparatus comprising the same | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2024-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12048240-B2 | Organic compound, electronic component and electronic apparatus comprising the same | PIEZO1, OCIAD1, OSTC | RXRA 2536/4885RXRB 2958/4885RXRG 3062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.